Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
260 participants
OBSERVATIONAL
2018-09-07
2019-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transdisciplinary Care for Young Adults With Type 1 Diabetes
NCT06172166
Transition of Adolescents and Young Adults With Diabetes From Pediatric to Adult Care
NCT01109797
Transition of Diabetes Care From Pediatric to Adult Healthcare Providers.
NCT03844126
Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes
NCT01351857
Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care
NCT03734107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This project has the potential to highlight T1D patients', their families, and providers' concerns and expectations regarding the transition process from a national sample which, could help develop recommendations to implement a patient-centered, successful transition process for emerging adults with T1D.
Specific aims:
Phase 1: To explore needs, expectations, and experiences of emerging adults with T1D, their parents, and healthcare providers around the transition process.
Phase 2: To conduct semi-structured interviews with participants from three stakeholder groups for in-depth understanding of the issues related to the transition process
Phase 3: To develop recommendations for a patient-centered transition process for emerging adults with T1D
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults with type 1 diabetes
People with T1D who are 18 years or older.
No interventions assigned to this group
Parents of adults with type 1 diabetes
Parents who have adult children with type 1 diabetes.
No interventions assigned to this group
Healthcare providers managing patients with type 1 diabetes
Licensed healthcare providers who are managing patients with T1D (whether in adult or pediatric practice).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults with T1D
* Parents of adults with T1D
* Healthcare providers caring for patients with T1D (in a pediatric or an adult care setting)
* Fluent in the English Language
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoag Memorial Hospital Presbyterian
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harsimran Singh, PhD
Role: PRINCIPAL_INVESTIGATOR
Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
147-18-DI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.